Blocking IFN-γ closely mimicked the effect of delayed clodronate treatment, reducing both the total number of macrophages (Fig. 7 D) in the tumor and the frequency of MHC class II–expressing macrophages, along with their expression levels on those macrophages (Fig. 7 E). The gene discussed is IFNG; the disease is neoplasm.